Curing hepatocellular carcinomatosis with biologic therapy and surgery

Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Thomas, Melanie (author)
مؤلفون آخرون: Tetzlaff, Eric (author), Lozano, Richard (author), Samp, Leigh (author), Butler, Charles (author), Gannon, Christopher (author), Hamilton, Stanley (author), Vauthey, Jean-Nicolas (author), Abdalla, Eddie (author)
التنسيق: article
منشور في: 2008
الوصول للمادة أونلاين:http://hdl.handle.net/10725/2593
http://dx.doi.org/10.1002/jso.2089
http://onlinelibrary.wiley.com/doi/10.1002/jso.20898/full
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513458682200064
author Thomas, Melanie
author2 Tetzlaff, Eric
Lozano, Richard
Samp, Leigh
Butler, Charles
Gannon, Christopher
Hamilton, Stanley
Vauthey, Jean-Nicolas
Abdalla, Eddie
author2_role author
author
author
author
author
author
author
author
author_facet Thomas, Melanie
Tetzlaff, Eric
Lozano, Richard
Samp, Leigh
Butler, Charles
Gannon, Christopher
Hamilton, Stanley
Vauthey, Jean-Nicolas
Abdalla, Eddie
author_role author
dc.creator.none.fl_str_mv Thomas, Melanie
Tetzlaff, Eric
Lozano, Richard
Samp, Leigh
Butler, Charles
Gannon, Christopher
Hamilton, Stanley
Vauthey, Jean-Nicolas
Abdalla, Eddie
dc.date.none.fl_str_mv 2008
2015-11-17T09:04:54Z
2015-11-17T09:04:54Z
2015-11-17
dc.identifier.none.fl_str_mv 0022-4790
http://hdl.handle.net/10725/2593
http://dx.doi.org/10.1002/jso.2089
Thomas, M. B., Tetzlaff, E., Lozano, R., Samp, L., Butler, C. E., Gannon, C., ... & Abdalla, E. (2008). Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?. Journal of surgical oncology, 97(1), 82-84.
http://onlinelibrary.wiley.com/doi/10.1002/jso.20898/full
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Journal of Surgical Oncology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Curing hepatocellular carcinomatosis with biologic therapy and surgery
Achieving the impossible?
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Hepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free. J. Surg. Oncol. 2008;97:82–84. © 2007 Wiley-Liss, Inc.
eu_rights_str_mv openAccess
format article
id LAURepo_4e5c8ca17f6fdb87d295539f4c49a8aa
identifier_str_mv 0022-4790
Thomas, M. B., Tetzlaff, E., Lozano, R., Samp, L., Butler, C. E., Gannon, C., ... & Abdalla, E. (2008). Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?. Journal of surgical oncology, 97(1), 82-84.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/2593
publishDate 2008
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Curing hepatocellular carcinomatosis with biologic therapy and surgeryAchieving the impossible?Thomas, MelanieTetzlaff, EricLozano, RichardSamp, LeighButler, CharlesGannon, ChristopherHamilton, StanleyVauthey, Jean-NicolasAbdalla, EddieHepatocellular carcinoma (HCC) that present as hemoperitoneum are uncommon, often recur as peritoneal carcinomatosis, and have poor prognosis. Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy. This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis. She received biologically targeted systemic therapy which resulted in significant radiographic tumor response. Salvage surgery revealed complete pathologic response in all tumor nodules, thus the patient was rendered cancer-free. J. Surg. Oncol. 2008;97:82–84. © 2007 Wiley-Liss, Inc.PublishedN/A2015-11-17T09:04:54Z2015-11-17T09:04:54Z20082015-11-17Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0022-4790http://hdl.handle.net/10725/2593http://dx.doi.org/10.1002/jso.2089Thomas, M. B., Tetzlaff, E., Lozano, R., Samp, L., Butler, C. E., Gannon, C., ... & Abdalla, E. (2008). Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?. Journal of surgical oncology, 97(1), 82-84.http://onlinelibrary.wiley.com/doi/10.1002/jso.20898/fullenJournal of Surgical Oncologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/25932019-02-26T08:19:50Z
spellingShingle Curing hepatocellular carcinomatosis with biologic therapy and surgery
Thomas, Melanie
status_str publishedVersion
title Curing hepatocellular carcinomatosis with biologic therapy and surgery
title_full Curing hepatocellular carcinomatosis with biologic therapy and surgery
title_fullStr Curing hepatocellular carcinomatosis with biologic therapy and surgery
title_full_unstemmed Curing hepatocellular carcinomatosis with biologic therapy and surgery
title_short Curing hepatocellular carcinomatosis with biologic therapy and surgery
title_sort Curing hepatocellular carcinomatosis with biologic therapy and surgery
url http://hdl.handle.net/10725/2593
http://dx.doi.org/10.1002/jso.2089
http://onlinelibrary.wiley.com/doi/10.1002/jso.20898/full